Kura Oncology (KURA) Interest & Investment Income (2015 - 2026)
Kura Oncology's (KURA) quarterly Interest & Investment Income came in at $5.8 million in Q1 2026, down 26.06% year-on-year from $7.9 million in Q1 2025, and down 26.06% on a QoQ basis from $7.9 million in Q1 2025.
Kura Oncology (KURA) Interest & Investment Income (2015 - 2026) Analysis & Trends
Kura Oncology (KURA) has 12 years of Interest & Investment Income data on file, last reported at $5.8 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 26.06% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 530.84% increase from a year earlier, with the FY2025 full-year figure at $26.8 million, up 1215.68% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $5.8 million, down from $7.9 million in the prior quarter.
- Over the last five years, Interest & Investment Income for KURA reached as high as $7.9 million in Q1 2025 and fell as low as -$15.2 million in Q4 2024.
- Historically, Interest & Investment Income has averaged $2.1 million across 5 years, with a median of $2.2 million in 2022.
- Across the five-year window, Interest & Investment Income surged 669.83% in 2022 and sank 298.44% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $2.3 million in 2022, then jumped by 236.28% to $7.6 million in 2023, then sank by 298.44% to -$15.2 million in 2024, then jumped by 151.99% to $7.9 million in 2025, then decreased by 26.06% to $5.8 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $5.8 million in Q1 2026, $7.9 million in Q1 2025, and -$15.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Kura Oncology | 916.67 Mn | 916.67 Mn | 18.00 Mn | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.83 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | -15.16 Mn |
| Sep 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 353,000.00 |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 674,000.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 564,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 311,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 310,000.00 |
| Dec 31, 2020 | 317,000.00 |
| Sep 30, 2020 | 571,000.00 |